This is a preview of subscription content, log in via an institution to check access.
Reference
Paggiaro P, et al. Stepping down from high dose fluticasone/salmeterol to extrafine BDP/F in asthma is cost-effective. Respiratory Medicine : 2 Aug 2013. Available from: URL: http://dx.doi.org/10.1016/j.rmed.2013.07.010
Additional information
* The study was funded by Chiesi Farmaceutici Spa, Italy. Two of the researchers were employees of that company.
** pressurised metered dose inhaler
Rights and permissions
About this article
Cite this article
Beclometasone/formoterol good value for money in asthma control. PharmacoEcon Outcomes News 685, 6 (2013). https://doi.org/10.1007/s40274-013-0644-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0644-7